Building Your Team and Staying Safe
At a Glance
Managing a Developmental and Epileptic Encephalopathy (DEE) requires a coordinated multidisciplinary team led by a pediatric epileptologist. Maximizing seizure control and utilizing nighttime monitoring are critical evidence-based strategies to reduce the risk of SUDEP in high-risk genetic DEEs.
Managing a Developmental and Epileptic Encephalopathy (DEE) requires more than just a single doctor; it requires a coordinated “medical home” that addresses every aspect of your child’s health and your family’s well-being [1][2]. Because DEEs involve multiple body systems, the goal is to build a multidisciplinary team that works together rather than in silos [3][4].
Your Multidisciplinary Care Roster
A comprehensive team for a child with DEE often includes:
- Pediatric Epileptologist: A neurologist who specializes specifically in difficult-to-treat epilepsy and is familiar with genetic precision medicine [5][6].
- Medical Geneticist: To help interpret complex genetic reports and stay informed about emerging gene-based clinical trials [7].
- Complex Care Pediatrician: Often acts as the “quarterback,” helping to coordinate care between specialists and manage general health [1].
- Gastroenterologist (GI): Essential for managing common DEE issues like severe constipation, reflux, or G-tube feeding [8].
- Physical, Occupational, and Speech Therapists (PT/OT/ST): To support developmental progress, manage movement disorders (like ataxia), and assist with communication and feeding safety [9][4].
- Social Worker or Care Coordinator: To help your family navigate insurance, school services, and the significant psychosocial impact of caregiving [2][10].
Understanding and Managing SUDEP Risk
Sudden Unexpected Death in Epilepsy (SUDEP) is a difficult but necessary topic for families of children with severe epilepsy. It refers to a death in a person with epilepsy that is not caused by injury, drowning, or a known illness [11].
Why Certain Genes Carry Higher Risk
While SUDEP is rare in the general epilepsy population, the risk is notably higher in certain genetic DEEs:
- SCN1A (Dravet Syndrome): The risk is higher due to a combination of frequent convulsive seizures and potential heart rhythm issues (arrhythmias) during or after a seizure [12][13].
- SCN8A: Research indicates a SUDEP risk of approximately 10% in this population, often related to cardiorespiratory failure following a seizure [14][15].
Evidence-Based Safety Strategies
While it may not be possible to eliminate risk entirely, research supports several strategies to improve safety:
- Maximize Seizure Control: The most effective way to reduce SUDEP risk is to reduce the frequency of Generalized Tonic-Clonic Seizures (GTCS) [16][11].
- Nocturnal Monitoring: Most SUDEP events occur during sleep [17]. Using baby monitors or specialized seizure-detection devices can help caregivers intervene quickly [18][19].
- Post-Seizure Positioning: After a convulsive seizure, if possible, place the child on their side (the recovery position) to keep their airway clear and avoid them lying face-down (prone) [20][21].
- Cardiac Screening: For children with SCN1A or SCN8A mutations, regular heart checks (ECGs) are often recommended to monitor for rhythm issues that may contribute to risk [22][23].
Vetting a New Specialist
When meeting a new neurologist, you have the right to ensure they have the expertise your child needs. Consider asking:
- “Are you familiar with the specific precision medicine guidelines for [Your Child’s Gene]?” [24][25]
- “How do you approach the use of rescue medications to prevent seizure clusters or status epilepticus?” [26]
- “Does your clinic have a dedicated Care Coordinator to help us manage our child’s multiple specialists?” [1]
Having an open, honest relationship with a knowledgeable team is your best tool for navigating the complexities of DEE [27][28].
Return to Home Page
Common questions in this guide
What type of doctors should be on my child's DEE care team?
What is SUDEP and why is it a concern for genetic DEEs?
How can I lower my child's risk of SUDEP?
What questions should I ask when vetting a new pediatric neurologist?
Get notified when new evidence is published on Genetic developmental and epileptic encephalopathy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (28)
- 1
Fulfilling the needs of caregivers in delivering health services to children with developmental and epileptic encephalopathies.
Kelada L, Best S, Pierce K, et al.
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2025; (54()):147-158 doi:10.1016/j.ejpn.2025.01.007.
PMID: 39919518 - 2
Systematic review of indirect costs to families of children with developmental epileptic encephalopathies.
Abdelmageed S, Du RY, Carroll M, et al.
Orphanet journal of rare diseases 2025; (20(1)):579 doi:10.1186/s13023-025-04081-9.
PMID: 41225515 - 3
Recommendations for the management of renal involvement in the tuberous sclerosis complex.
Ariceta G, Buj MJ, Furlano M, et al.
Nefrologia 2020; (40(2)):142-151 doi:10.1016/j.nefro.2019.07.002.
PMID: 31722796 - 4
Use of the ketogenic diet to manage refractory epilepsy in CDKL5 disorder: Experience of >100 patients.
Lim Z, Wong K, Olson HE, et al.
Epilepsia 2017; (58(8)):1415-1422 doi:10.1111/epi.13813.
PMID: 28605011 - 5
Association of quality of paediatric epilepsy care with mortality and unplanned hospital admissions among children and young people with epilepsy in England: a national longitudinal data linkage study.
Hargreaves DS, Arora S, Viveiro C, et al.
The Lancet. Child & adolescent health 2019; (3(9)):627-635 doi:10.1016/S2352-4642(19)30201-9.
PMID: 31281027 - 6
Updates on the diagnostic evaluation, genotype-phenotype correlation, and treatments of genetic epilepsies.
Zimmern V, Korff C
Current opinion in pediatrics 2022; (34(6)):538-543 doi:10.1097/MOP.0000000000001170.
PMID: 36081356 - 7
Exome sequencing for patients with developmental and epileptic encephalopathies in clinical practice.
Scheffer IE, Bennett CA, Gill D, et al.
Developmental medicine and child neurology 2023; (65(1)):50-57 doi:10.1111/dmcn.15308.
PMID: 35701389 - 8
Gastrointestinal Symptoms and Channelopathy-Associated Epilepsy.
Beck VC, Isom LL, Berg AT
The Journal of pediatrics 2021; (237()):41-49.e1 doi:10.1016/j.jpeds.2021.06.034.
PMID: 34181986 - 9
Quantification of neuromotor control in STXBP1 -Related Disorders with wearable sensors.
Orlando JM, Bane B, Chisari T, et al.
medRxiv : the preprint server for health sciences 2025; doi:10.1101/2025.09.20.25336193.
PMID: 41040694 - 10
Caregiver-reported meaningful change in functional domains for individuals with developmental and epileptic encephalopathy: A convergent mixed-methods design.
Downs J, Haywood S, Ludwig NN, et al.
Developmental medicine and child neurology 2025; (67(12)):1616-1627 doi:10.1111/dmcn.16363.
PMID: 40372822 - 11
Postictal Death Is Associated with Tonic Phase Apnea in a Mouse Model of Sudden Unexpected Death in Epilepsy.
Wenker IC, Teran FA, Wengert ER, et al.
Annals of neurology 2021; (89(5)):1023-1035 doi:10.1002/ana.26053.
PMID: 33604927 - 12
Cardiac arrhythmias in Dravet syndrome: an observational multicenter study.
Shmuely S, Surges R, Helling RM, et al.
Annals of clinical and translational neurology 2020; (7(4)):462-473 doi:10.1002/acn3.51017.
PMID: 32207228 - 13
Enhancing the action of serotonin by three different mechanisms prevents spontaneous seizure-induced mortality in Dravet mice.
Guo J, Min D, Farrell EK, et al.
Epilepsia 2024; (65(6)):1791-1800 doi:10.1111/epi.17966.
PMID: 38593237 - 14
SCN8A-related developmental and epileptic encephalopathy with ictal asystole requiring cardiac pacemaker implantation.
Negishi Y, Aoki Y, Itomi K, et al.
Brain & development 2021; (43(7)):804-808 doi:10.1016/j.braindev.2021.03.004.
PMID: 33827760 - 15
Dentate gyrus granule cells are a locus of pathology in Scn8a developmental encephalopathy.
Yu W, Hill SF, Zhu L, et al.
Neurobiology of disease 2024; (199()):106591 doi:10.1016/j.nbd.2024.106591.
PMID: 38969233 - 16
Waiting to Inhale: Preventing Fatality From Seizure-Induced Apnea.
Wenker IC, Patel MK
Epilepsy currents 2023; (23(3)):185-187 doi:10.1177/15357597231159466.
PMID: 37334424 - 17
A population-based post mortem study of sudden unexpected death in epilepsy.
Clark D, Riney K
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2016; (23()):58-62 doi:10.1016/j.jocn.2015.04.027.
PMID: 26387918 - 18
Wearable seizure detection devices in refractory epilepsy.
Verdru J, Van Paesschen W
Acta neurologica Belgica 2020; (120(6)):1271-1281 doi:10.1007/s13760-020-01417-z.
PMID: 32632710 - 19
Autonomic manifestations of epilepsy: emerging pathways to sudden death?
Thijs RD, Ryvlin P, Surges R
Nature reviews. Neurology 2021; (17(12)):774-788 doi:10.1038/s41582-021-00574-w.
PMID: 34716432 - 20
The probability of sudden unexpected death in epilepsy given postictal prone position.
Esmaeili B, Dworetzky BA, Glynn RJ, Lee JW
Epilepsy & behavior : E&B 2021; (116()):107775 doi:10.1016/j.yebeh.2021.107775.
PMID: 33571837 - 21
Nocturnal seizures are associated with more severe hypoxemia and increased risk of postictal generalized EEG suppression.
Latreille V, Abdennadher M, Dworetzky BA, et al.
Epilepsia 2017; (58(9)):e127-e131 doi:10.1111/epi.13841.
PMID: 28714130 - 22
Intersection of epilepsy and cardiac health: Insights from electrocardiography and syndromic associations.
Akyuz E, Aslan FS, Eyigurbuz T
Epilepsia 2025; (66(10)):3656-3675 doi:10.1111/epi.18502.
PMID: 40512607 - 23
Cardiac arrhythmias in sudden unexpected death in epilepsy: A systematic review.
Ermongkonchai T, Kwok M, Prinsloo D, et al.
Epilepsy & behavior : E&B 2025; (171()):110582 doi:10.1016/j.yebeh.2025.110582.
PMID: 40618461 - 24
Solute carrier transporter disease and developmental and epileptic encephalopathy.
Gan Y, Wei Z, Liu C, et al.
Frontiers in neurology 2022; (13()):1013903 doi:10.3389/fneur.2022.1013903.
PMID: 36419532 - 25
Targeted gene panel sequencing in early infantile onset developmental and epileptic encephalopathy.
Na JH, Shin S, Yang D, et al.
Brain & development 2020; (42(6)):438-448 doi:10.1016/j.braindev.2020.02.004.
PMID: 32139178 - 26
Genetic and clinical features of SCN8A developmental and epileptic encephalopathy.
Kim HJ, Yang D, Kim SH, et al.
Epilepsy research 2019; (158()):106222 doi:10.1016/j.eplepsyres.2019.106222.
PMID: 31675620 - 27
Sudden unexpected death in epilepsy disclosure causes anxiety in patients with epilepsy: a Chinese questionnaire survey.
Pan Y, Hu G, Wang Z, et al.
Frontiers in neurology 2023; (14()):1284050 doi:10.3389/fneur.2023.1284050.
PMID: 38033778 - 28
Real-World Practices in Educating Patients and Caregivers About Sudden Unexpected Death in Epilepsy: A Scoping Review.
Alzahrani LA, Aldweesh AF, Alotaibi AN, et al.
Saudi journal of medicine & medical sciences 2026; (14(1)):4-13 doi:10.4103/sjmms.sjmms_114_25.
PMID: 41675952
This page provides educational information about building a care team and managing SUDEP risks for children with DEE. It does not replace professional medical advice from your child's pediatric epileptologist or care team.